Concepedia

Publication | Closed Access

Evaluation of immunogenicity of the T cell costimulation modulator abatacept in patients treated for rheumatoid arthritis.

59

Citations

0

References

2007

Year

Helen G. Haggerty, Mark A. Abbott, Timothy P. Reilly, Deborah A DeVona, Carol Gleason, Lee K. Tay, Robert Dodge, Richard Aranda
PubMed

Abstract

Abatacept was associated with a low incidence of immunogenicity in patients with RA and lacked any adverse sequelae.